MedPath

Cryolipolisis for Abdomen and Flank Fat Reduction

Not Applicable
Completed
Conditions
Subcutaneous Fat Disorder
Interventions
Device: Contrast Cryolipolysis
Device: Conventional Cryolipolysis
Device: Reperfusion Cryolipolysis
Registration Number
NCT03033004
Lead Sponsor
Universidade Cidade de Sao Paulo
Brief Summary

Sixty healthy subjects aged between 18 and 50 will be randomly allocated into three treatment groups: Conventional Cryolipolysis, Contrast Cryolipolysis or Recovery Reperfusion Cryolipolysis. The region will be treated according to the individual need, in the region of abdomen and flanks. Assessments of body composition will be performed at baseline and 30, 60 and 90 days after randomization. Blood collections will also be performed at baseline and between 14 and 21 days after randomization for evaluation of lipid profile and liver function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Healthy subjects
  • Body mass index > 29.9 Kg/m2
Exclusion Criteria
  • Pregnancy
  • Diabetes
  • Cancer
  • Vascular diseases
  • Heart diseases
  • Liposuction or other surgical procedures for body contouring
  • Active infection
  • Wounds
  • Paroxysmal cold hemoglobinuria
  • Cold urticaria
  • Significant weight changes in the past 3 months or during treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Contrast CryolipolysisContrast CryolipolysisSubjects will receive one treatment session of contrast cryolipolisys. Subcutaneous fat tissue will be heated for 10 minutes, cooled for 60 minutes, and heated again for 10 minutes with the cryolipolitic device. The treatmente area will be the abdomen and/or flanks according to each patient's needs (pragmatic treatment).
Conventional CryolipolysisConventional CryolipolysisSubjects will receive one treatment session of conventional cryolipolisys. Subcutaneous fat tissue will be cooled with the cryolipolitic device for 60 minutes. The treatmente area will be the abdomen and/or flanks according to each patient's needs (pragmatic treatment).
Reperfusion CryolipolysisReperfusion CryolipolysisSubjects will receive one treatment session of Reperfusion Cryolipolysis. Subcutaneous fat tissue will be cooled with the cryolipolitic device for 60 minutes and heated for 10 minutes. The treatmente area will be the abdomen and/or flanks according to each patient's needs (pragmatic treatment).
Primary Outcome Measures
NameTimeMethod
Fat layer thickness changes measured by ultrasound90 days after randomization
Secondary Outcome Measures
NameTimeMethod
Changes in fasting blood glucose21 days after randomization
Changes in body weight90 days after randomization
Changes in skin viscoelasticity measured by a cutometer90 days after randomization
Changes in circumference measurements90 days after randomization
Fat layer thickness changes measured by ultrasound60 days after randomization
Changes in cholesterol levels21 days after randomization

Cholesterol levels will be measured in mg/dL

Changes in triglyceride levels21 days after randomization

Triglyceride levels will be measured in mg/dL

Changes in blood levels of alanine aminotransferase (ALT)21 days after randomization
Changes in blood levels of aspartate transaminase (AST)21 days after randomization
Subject's satisfaction with regard to treatment measued by a numeric scale ranging from 1 to 3.90 days after randomization

1= unsatisfied; 2= indifferent; 3= satisfied

Subject's tolerance with regard to treatment measued by a numeric scale ranging from 1 to 3.90 days after randomization

1 = intolerable; 2= tolerable; 3= comfortable

Trial Locations

Locations (1)

Centro de Estudos e Formação Avançada Ibramed.

🇧🇷

Amparo, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath